TrialReader


Capturing Physiologic Autonomic Data from Clinically Indicated Magnetic Resonance Imaging Scans in Children

NCT06110689 — Completed, 40 participants, Children's Hospital Medical Center, Cincinnati

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT06110689, acronym CMRI
StatusCompleted
Study typeObservational
Enrollment40 (Actual)
SponsorChildren's Hospital Medical Center, Cincinnati (Other)
ConditionsPectus Excavatum, Cardiac Anomaly
InterventionsVU-AMS device (Other)
Datesstart 2023-10-03, primary completion 2024-11-25, completion 2024-11-25, first posted 2023-11-01, last updated 2025-01-29
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Pectus Excavatum All trials for Cardiac Anomaly All trials of VU-AMS device

-Summary

The Fontan Procedure is a palliative surgical procedure used in pediatric patients with one functional ventricle. The procedure, a series of stepwise operations that alter cardiorespiratory physiology, separate the systemic and pulmonary circulations to create Fontan physiology, where the systemic venous blood flows passively and without ventricular thrust into the pulmonary circulation. The hallmark of the Fontan circulation is a sustained, abnormally elevated central venous pressure combined with decreased cardiac output, especially during periods of increased demands. Results of several studies in Fontan patients have shown reduced parasympathetic and sympathetic activity compared to controls. In children with congenital heart disease, a differential diagnosis of autonomic dysfunction may be part of their pathophysiology, a compensatory mechanism, a consequence of surgical procedures or a combination of these.

In children, measurement of ANS function is equally important. Children with single ventricle physiology (and other cardiac conditions) have routine surveillance and cardiac magnetic resonance (CMR) imaging to monitor for disease progression. While autonomic data is routinely collected and is available from these scans, these data are rarely, collected and analyzed; however, our group has shown feasibility. Therefore, autonomic data is usually unavailable in children. Despite the availability of agerelated normal values, the predictive power of autonomic activity is understudied in children and there are no published studies of quantification of autonomic data in this population.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
FontanOther: VU-AMS devicePatients undergoing cardiac MRI for Fontan,
Healthy controlsOther: VU-AMS devicePatients undergoing thoracic MRI for chest wall deformity.
  • VU-AMS device (Other): Patients will wear the VU-AMS monitor prior to MRI.

+Outcome measures

Primary outcomes

  • 80% availability of respiratory sinus arrhythmia from cardiac MRI (magnetic resonance imaging) [Through MRI completion up to one hour]: Data collected during MRI

Other outcomes

  • Describe difference in respiratory sinus arrhythmia in participants with Fontan [Through MRI completion up to one hour]: Collection of data from the cardiac MRI
  • Describe difference in respiratory sinus arrhythmia in participants with pectus [Through MRI completion up to one hour]: Collection of data from the cardiac MRI
  • Compare estimate of pre-ejection period (PEP) [Prior to MRI scan up to 10 minutes]: Collection of data from VU-AMS monitor
  • Compare estimate of pre-ejection period (PEP) [Through MRI completion up to one hour]: Collection of data from the cardiac MRI

+Eligibility

Sex: All, ages: 1 Day to 30 Years

Inclusion Criteria:

* Ages 0 to ≤ 30 years
* Baseline sinus rhythm (interventricular conduction delays and bundle branch blocks allowed); and undergoing CMR scan in which sequences containing timing of aortic valve opening (cine), vector cardiogram (VCG) and respiratory bellows use will be obtained
* Fontan physiology - only for the Fontan group. Chest wall deformity or arrhythmogenic right ventricular cardiomyopathy for the healthy control group

Exclusion Criteria:

* Patient or family refusal;
* Contraindication to study procedures
* Prior participation in the study (ie, we plan to sample without replacement)

+Locations (1)

FacilityCityCountryStatus
Cincinnati Children's Hospital Medical CenterCincinnati, OhioUnited States

+Investigators

My Notes